Compare · CANO vs CHE
CANO vs CHE
Side-by-side comparison of Cano Health Inc. (CANO) and Chemed Corp (CHE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CANO and CHE operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $7.11B, about 7.5x CANO ($949.0M).
- CHE has hit the wire 7 times in the past 4 weeks while CANO has been quiet.
- CANO has more recent analyst coverage (22 ratings vs 6 for CHE).
- Company
- Cano Health Inc.
- Chemed Corp
- Price
- -
- -
- Market cap
- $949.0M
- $7.11B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 7
- Recent ratings
- 22
- 6
Cano Health Inc.
Cano Health, LLC owns and operates health care centers and pharmacies. It provides medical, dental, urgent care, an in-house laboratory, and specialty services. The company offers patient-centric programs, such as home visits, telehealth, transition of care, and high risk and complex care management. Cano Health, LLC was founded in 2009 and is based in Miami, Florida.
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest CANO
- Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan
- SEC Form SC 13G/A filed by Cano Health Inc. (Amendment)
- Cano Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form SC 13D/A filed by Cano Health Inc. (Amendment)
- Cano Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
- SEC Form 25-NSE filed by Cano Health Inc.
- SEC Form 8-K filed by Cano Health Inc.
- NYSE Suspends Trading n Cano Health And Begins Delisting Proceedings
- NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings
- Cano Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure
Latest CHE
- Executive vice president Lee Spencer S sold $541,040 worth of Capital Stock (1,000 units at $541.04), decreasing direct ownership by 7% to 13,912 units (SEC Form 4)
- President and CEO Mcnamara Kevin J sold $1,082,320 worth of Capital Stock (2,000 units at $541.16), decreasing direct ownership by 3% to 70,418 units (SEC Form 4)
- VP and Chief Legal Officer Judkins Brian C exercised 6,786 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 5,878 units of Capital Stock, increasing direct ownership by 37% to 3,344 units (SEC Form 4)
- CEO - Vitas Healthcare Wherley Joel L exercised 2,599 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 2,270 units of Capital Stock, increasing direct ownership by 39% to 1,181 units (SEC Form 4)
- Chemed Corporation Declares Quarterly Dividend of 70 Cents
- President and CEO Mcnamara Kevin J covered exercise/tax liability with 19,802 units of Capital Stock, sold $1,079,020 worth of Capital Stock (2,000 units at $539.51) and exercised 2,001 units of Capital Stock at a strike of $445.35, decreasing direct ownership by 22% to 70,418 units (SEC Form 4)
- Director Grace Patrick P sold $101,080 worth of Capital Stock (190 units at $532.00), decreasing direct ownership by 5% to 3,533 units (SEC Form 4)
- SEC Form 10-Q filed by Chemed Corp
- Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chemed Reports Second-Quarter 2026 Results